These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30945381)

  • 61. Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.
    Cronin-Fenton DP; Heide-Jørgensen U; Ahern TP; Lash TL; Christiansen P; Ejlertsen B; Sørensen HT
    Epidemiology; 2016 Jul; 27(4):586-93. PubMed ID: 27007644
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Use of beta-blockers and risk of contralateral breast cancer.
    Gottschau M; Bens A; Friis S; Cronin-Fenton D; Aalborg GL; Jensen MB; Ejlertsen B; Kroman N; Mellemkjaer L
    Int J Cancer; 2022 May; 150(10):1619-1626. PubMed ID: 34985760
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Enhancing Breast Cancer Recurrence Algorithms Through Selective Use of Medical Record Data.
    Kroenke CH; Chubak J; Johnson L; Castillo A; Weltzien E; Caan BJ
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26582243
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Opioid use and adverse health effects in breast cancer survivors.
    Haque R; Chen LH; Shi J; Gu Z; Brady-Rogers M; Chlebowski RT; Hechter RC
    Oncologist; 2024 Oct; ():. PubMed ID: 39401323
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pregnancy-associated cancer and the risk of second primary cancer.
    Mellemkjær L; Eibye S; Albieri V; Kjær SK; Boice JD
    Cancer Causes Control; 2022 Jan; 33(1):63-71. PubMed ID: 34643832
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comprehensive evaluation of the incidence of late effects in 5-year survivors of breast cancer.
    Lash TL; Thwin SS; Yood MU; Geiger AM; Bosco J; Quinn VP; Field TS; Pawloski PA; Silliman RA
    Breast Cancer Res Treat; 2014 Apr; 144(3):643-63. PubMed ID: 24584822
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study.
    Scott OW; Tin Tin S; Elwood JM; Cavadino A; Habel LA; Kuper-Hommel M; Campbell I; Lawrenson R
    Breast Cancer Res Treat; 2022 May; 193(1):225-235. PubMed ID: 35286523
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The impact of intraoperative opioid use on survival after oral cancer surgery.
    Patino MA; Ramirez RE; Perez CA; Feng L; Kataria P; Myers J; Cata JP
    Oral Oncol; 2017 Nov; 74():1-7. PubMed ID: 29103736
    [TBL] [Abstract][Full Text] [Related]  

  • 69. New method for determining breast cancer recurrence-free survival using routinely collected real-world health data.
    Jung H; Lu M; Quan ML; Cheung WY; Kong S; Lupichuk S; Feng Y; Xu Y
    BMC Cancer; 2022 Mar; 22(1):281. PubMed ID: 35296284
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of opioids and mu-opioid receptors on oncologic metastasis.
    Wang R; Li S; Wang B; Wang G; Zheng H
    Am J Cancer Res; 2024; 14(9):4236-4247. PubMed ID: 39417177
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Opioids and Cancer: Current Understanding and Clinical Considerations.
    Sah D; Shoffel-Havakuk H; Tsur N; Uhelski ML; Gottumukkala V; Cata JP
    Curr Oncol; 2024 May; 31(6):3086-3098. PubMed ID: 38920719
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The association between perioperative opioids and breast cancer recurrence: a narrative review of the literature.
    Thomas TE; Bowers K; Gomez D; Morgan O; Borowsky PA; Dutta R; Abu Y; Roy S; Rojas KE
    Transl Breast Cancer Res; 2023; 4():12. PubMed ID: 38751469
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The influence of anaesthesia on cancer growth.
    Potocnik I; Kerin-Povsic M; Markovic-Bozic J
    Radiol Oncol; 2024 Mar; 58(1):9-14. PubMed ID: 38378027
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antitumor Anesthetic Strategy in the Perioperatory Period of the Oncological Patient: A Review.
    Santander Ballestín S; Lanuza Bardaji A; Marco Continente C; Luesma Bartolomé MJ
    Front Med (Lausanne); 2022; 9():799355. PubMed ID: 35252243
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Opioids and Breast Cancer Recurrence: A Systematic Review.
    Lucia M; Luca T; Federica DP; Cecilia G; Chiara M; Laura M; Carlo DR; Grazia PM
    Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771662
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anaesthesia as an influence in tumour progression.
    Plücker J; Wirsik NM; Ritter AS; Schmidt T; Weigand MA
    Langenbecks Arch Surg; 2021 Aug; 406(5):1283-1294. PubMed ID: 33523307
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risk of second breast cancer events with chronic opioid use in breast cancer survivors.
    Boudreau DM; Chen L; Yu O; Bowles EJA; Chubak J
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):740-753. PubMed ID: 30945381
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Associations between diabetes medication use and risk of second breast cancer events and mortality.
    Calip GS; Yu O; Hoskins KF; Boudreau DM
    Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Frequent antibiotic use and second breast cancer events.
    Wirtz HS; Buist DS; Gralow JR; Barlow WE; Gray S; Chubak J; Yu O; Bowles EJ; Fujii M; Boudreau DM
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1588-99. PubMed ID: 23833124
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.
    Boudreau DM; Yu O; Chubak J; Wirtz HS; Bowles EJ; Fujii M; Buist DS
    Breast Cancer Res Treat; 2014 Apr; 144(2):405-16. PubMed ID: 24557337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.